PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29790290-0	2018	Tacrolimus prevents von Willebrand factor secretion by allostimulated human glomerular endothelium.	Tacrolimus	0-10	von Willebrand factor	Homo sapiens	20-41	
29790290-5	2018	Therefore, we hypothesized that tacrolimus would prevent alloantibody-induced glomerular lesions, in part via inhibition of vWF secretion from endothelial cells.	Tacrolimus	32-42	von Willebrand factor	Homo sapiens	124-127	
29790290-7	2018	We observed that tacrolimus treatment decreased vWF secretion after stimulation with both classes of anti-HLA antibodies and decreased platelet adhesion on allostimulated endothelial cells in a microfluidic chamber.	Tacrolimus	17-27	von Willebrand factor	Homo sapiens	48-51	
29790290-8	2018	In kidney recipients, tacrolimus trough levels were negatively associated with vWF blood levels.	Tacrolimus	22-32	von Willebrand factor	Homo sapiens	79-82